Developing the business case for bringing cancer testing in-house can be a daunting task for laboratory, pathology, and other scientific professionals. In this presentation, Dr. Gregory Tranah, of Sutter Health, discusses opportunities and challenges that bringing in-house testing to a large, complex, health system presents. Dr. Tranah will discuss critical success factors such as personalization, portability, safety, and accessibility for others who are considering embarking on this path.

 

Back

Recent Resources

Blog

August 30, 2022

CGC 2022 Key Takeaways

NGS Reporting, Whole Genome Sequencing, and In-House Testing major themes in this year’s meeting